The chemical class referred to as Synaptotagmin I inhibitors comprises a diverse group of organic compounds recognized for their unique capacity to selectively modulate the activity of Synaptotagmin I. Synaptotagmin I is a pivotal protein involved in orchestrating synaptic vesicle exocytosis and neurotransmitter release within neuronal cells. These inhibitors exert their effects by interacting with specific binding sites associated with Synaptotagmin I, potentially influencing its interactions with other proteins and, consequently, its role in mediating vesicle fusion and neurotransmitter secretion. By targeting Synaptotagmin I, these inhibitors contribute to a nuanced control of synaptic transmission dynamics.
The chemical structures of Synaptotagmin I inhibitors exhibit a wide range of molecular arrangements, reflecting the ongoing scientific quest to understand their precise mechanisms of action. As researchers continue to explore the intricate mechanisms governing synaptic function, inhibitors directed at Synaptotagmin I offer valuable tools for investigating the complex molecular processes that underlie synaptic communication.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
N-Ethylmaleimide | 128-53-0 | sc-202719A sc-202719 sc-202719B sc-202719C sc-202719D | 1 g 5 g 25 g 100 g 250 g | $22.00 $68.00 $210.00 $780.00 $1880.00 | 19 | |
NEM is a compound that can modify and inhibit SNARE proteins, potentially affecting Synaptotagmin I-mediated vesicle release. | ||||||